Sang-Cheol Chi

Title: Sang-Cheol Chi: Innovator in Transdermal Gel Technology

Introduction

Sang-Cheol Chi is a notable inventor based in Gyeonggi, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of transdermal gels. His innovative approach has led to advancements that enhance the effectiveness and safety of pain relief treatments.

Latest Patents

Sang-Cheol Chi holds a patent for an anti-inflammatory and analgesic transdermal gel. This gel comprises several key components, including ketoprofen as the effective ingredient, poloxamer, and various agents such as ethyl alcohol and glycerin. The formulation also includes fatty acids and menthol, which contribute to its effectiveness. The resulting gels form thin and pliable films that are easily washable with water. They are designed to provide prolonged anti-inflammatory and analgesic activities while minimizing systemic side effects and gastric irritation.

Career Highlights

Chi is associated with Ildong Pharm Co., Ltd., where he has been instrumental in advancing pharmaceutical technologies. His work focuses on creating innovative solutions that improve patient care and treatment outcomes. His dedication to research and development has positioned him as a key figure in the industry.

Collaborations

Sang-Cheol Chi has collaborated with notable colleagues, including Hyun-Kwang Tan and Heung-Won Chun. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Sang-Cheol Chi's contributions to transdermal gel technology exemplify his commitment to improving healthcare solutions. His innovative patent reflects a significant advancement in the field, showcasing his expertise and dedication to enhancing patient care.